Design, synthesis, and structure-affinity relationships of novel series of sialosides as CD22-specific inhibitors.

Sialosides incorporating substituted amides or amines at 9-position of sialic acid moiety have been synthesized and evaluated as CD22 inhibitors. Several derivatives exhibited inhibitory potency in sub- to low micromolar range (e. g., 8o, 9d, 9g, and 9k showed IC50 values 0.40, 0.47, 0.24, and 0.23 μM, respectively, for hCD22, while 8p, 8q, and 9f, showed IC50 values 1.70, 2.90, and 4.10 μM, respectively, for mCD22). The most significant result was the strongly enhanced affinity of 9g and 9k containing 9-(2′ or 4′-hydroxy-4-biphenyl) methylamino substituents (600-fold more potent for hCD22 than the corresponding 9-hydroxy derivative; 7a). Molecular modeling study was carried out to get some insights into the molecular basis of CD22 inhibition. To the best of our knowledge, this is the first systematic structure−affinity relationship study on inhibition of CD22.